BLRX — BioLine RX Balance Sheet
0.000.00%
HealthcareSpeculativeSmall CapMomentum Trap
- $89.48m
- $42.60m
- 18
- 30
- 77
- 36
Annual balance sheet for BioLine RX, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 49.5 | 30.2 | 27.5 | 22.6 | 57.1 |
Net Total Receivables | 0.586 | 1.34 | 0.613 | 0.141 | 0.142 |
Prepaid Expenses | |||||
Total Current Assets | 50.4 | 32 | 28.2 | 22.9 | 57.4 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.5 | 2.23 | 3.47 | 2.7 | 2.28 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 61 | 56.2 | 53.6 | 47.3 | 81.4 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.72 | 6.75 | 12 | 10.6 | 9.72 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 8.08 | 14.9 | 20.2 | 25.3 | 13.3 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 52.9 | 41.3 | 33.4 | 22 | 68.1 |
Total Liabilities & Shareholders' Equity | 61 | 56.2 | 53.6 | 47.3 | 81.4 |
Total Common Shares Outstanding |